Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tran

Showing results (521-530 of 540) with videos related to

Pageof 54
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Journal of Medicinal Chemistry|October 27, 2006
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organismsEdmund L Ellsworth, Tuan P Tran, H D Hollis Showalter, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189Antonia F Stepan, Tuan P Tran, Christopher J Helal, et al.
Microbiology Resource Announcements|February 15, 2024
Draft genome sequence of <i>Exiguobacterium</i> sp. strain MMG028 isolated from a salt marshMorgan V Farrell, Mina Y Airkin, Tatyana N Ali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2022
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysisH Borghaei, T-E Ciuleanu, J-S Lee, et al.
Journal of Medicinal Chemistry|January 17, 2014
Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
ESMO Open|December 5, 2021
Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273]M Reck, T-E Ciuleanu, M Cobo, et al.
ESMO Open|October 4, 2021
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year updateM Reck, T-E Ciuleanu, M Cobo, et al.
The Journal of Clinical Investigation|October 12, 2023
Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumenYe Yang, Anne P Beigneux, Wenxin Song, et al.
The Journal of Clinical Investigation|October 1, 2025
GPIHBP1, lipoprotein lipase, and triglyceride-rich lipoproteins in capillaries of the choroid plexus and circumventricular organsWenxin Song, Madison Hung, Ellen Kozlov, et al.
Pageof 54

Showing results (521-530 of 540) with videos related to

Sort By:
Pageof 54
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Journal of Medicinal Chemistry|October 27, 2006
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organismsEdmund L Ellsworth, Tuan P Tran, H D Hollis Showalter, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189Antonia F Stepan, Tuan P Tran, Christopher J Helal, et al.
Microbiology Resource Announcements|February 15, 2024
Draft genome sequence of <i>Exiguobacterium</i> sp. strain MMG028 isolated from a salt marshMorgan V Farrell, Mina Y Airkin, Tatyana N Ali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2022
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysisH Borghaei, T-E Ciuleanu, J-S Lee, et al.
Journal of Medicinal Chemistry|January 17, 2014
Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
ESMO Open|December 5, 2021
Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273]M Reck, T-E Ciuleanu, M Cobo, et al.
ESMO Open|October 4, 2021
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year updateM Reck, T-E Ciuleanu, M Cobo, et al.
The Journal of Clinical Investigation|October 12, 2023
Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumenYe Yang, Anne P Beigneux, Wenxin Song, et al.
The Journal of Clinical Investigation|October 1, 2025
GPIHBP1, lipoprotein lipase, and triglyceride-rich lipoproteins in capillaries of the choroid plexus and circumventricular organsWenxin Song, Madison Hung, Ellen Kozlov, et al.
Pageof 54